“…These studies were conducted in North America ( n = 5) ( 22 – 26 ), Europe ( n = 10) ( 14 , 27 – 35 ), Asia ( n = 9) ( 19 , 36 – 43 ), Africa ( n = 1) ( 44 ), Australia and New Zealand ( n = 6) ( 45 – 50 ), South America ( n = 1) ( 13 ). We included participants who were diagnosed with MI ( 24 , 29 , 32 , 34 , 35 , 37 , 44 , 47 ), ACS ( 14 , 22 , 31 , 33 , 49 ), CHD ( 13 , 19 , 23 , 27 , 28 , 30 , 40 , 41 , 45 , 46 , 48 , 50 ), Ischemic stroke ( 13 , 30 ) and PAD ( 13 , 19 , 30 ) or received coronary revascularization ( 13 , 19 , 23 , 25 , 26 , 28 , 29 , 33 , 36 , 38 , 39 , 42 , 43 , 45 , 48 , 49 ) in our review. The participants’ mean age varies from 55.8 to 70.36 and 20.04% of them are female.…”